Agilon Health, Inc.
AGL · NYSE
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Market Cap | $781 | $5,132 | $6,588 | $10,803 |
| - Cash | $188 | $108 | $497 | $1,040 |
| + Debt | $44 | $52 | $43 | $48 |
| Enterprise Value | $637 | $5,077 | $6,134 | $9,811 |
| Revenue | $6,061 | $4,316 | $2,388 | $1,521 |
| % Growth | 40.4% | 80.7% | 57% | – |
| Gross Profit | $5 | $70 | $111 | $66 |
| % Margin | 0.1% | 1.6% | 4.7% | 4.3% |
| EBITDA | -$218 | -$168 | -$72 | -$362 |
| % Margin | -3.6% | -3.9% | -3% | -23.8% |
| Net Income | -$260 | -$263 | -$107 | -$406 |
| % Margin | -4.3% | -6.1% | -4.5% | -26.7% |
| EPS Diluted | -0.63 | -0.64 | -0.26 | -1.09 |
| % Growth | 1.6% | -146.2% | 76.1% | – |
| Operating Cash Flow | -$58 | -$156 | -$131 | -$148 |
| Capital Expenditures | -$13 | -$31 | -$33 | -$13 |
| Free Cash Flow | -$71 | -$187 | -$163 | -$162 |